rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    ZURA
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Zura Bio: A 70% Collapse Doesn't Mean The Science Is Dead

      Analyst rates Zura Bio a Hold: illustrative $1.45 fair value implies 17% upside, insufficient ahead of TibuSURE's H1 2027 Phase 2 readout.

      Nov 16Seeking AlphaZURA
      ZURA SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Zura Bio Limited
      Nov 10MorningstarZURA
      Guggenheim cuts Zura Bio stock price target to $8 on trial failure
      Nov 10Investing.comZURA
      Zura Bio discontinues tibulizumab in HS after Phase II trial failure
      Nov 10Yahoo FinanceZURA
      Crude Oil Falls Over 3%; NRG Energy Shares Jump After Strong Q3 Results
      Nov 9BenzingaDCTHZURANRG
      Zura Bio Discontinues Hidradenitis Suppurativa Development After Phase 2 Tibulizumab Trial Misses Endpoints
      Nov 9Yahoo FinanceZURA
      Why is Zura Bio stock collapsing today?
      Nov 9Investing.comZURA
      Zura Bio’s tibulizumab fails phase 2 trial for skin disease
      Nov 9Investing.comZURA
      Zura Bio Provides Clinical Update on Phase 2 TibuSHIELD Study of Tibulizumab (ZB-106) in Hidradenitis Suppurativa
      Nov 9Yahoo FinanceZURA
      Guggenheim reiterates Zura Bio stock rating on HS market potential
      Oct 30Investing.comZURA
      Zura Bio shares jump on Wedbush buy call ahead of trial data
      Oct 27Investing.comZURA
      Analysts Are Bullish on These Healthcare Stocks: Zura Bio (ZURA), Alphatec Holdings (ATEC)

      Detailed price information for Zura Bio Ltd (ZURA-Q) from The Globe and Mail including charting and trades.

      Oct 8The Globe and MailZURA
      This biotech stock is a top pick at Guggenheim
      Oct 7Yahoo FinanceZURA
      8 Tickers To Watch This Week (NASDAQ:ZURA)
      Oct 5Seeking AlphaZURA
      Leerink Partners Reaffirms Their Buy Rating on Zura Bio (ZURA)

      Detailed price information for Zura Bio Ltd (ZURA-Q) from The Globe and Mail including charting and trades.

      Oct 3The Globe and MailZURA
      Guggenheim Keeps Their Buy Rating on Zura Bio (ZURA)

      Detailed price information for Zura Bio Ltd (ZURA-Q) from The Globe and Mail including charting and trades.

      Oct 3The Globe and MailZURA
      Zura Bio (ZURA) Hits Enrollment Milestones As Losses Widen Sharply

      On August 11, Zura Bio (NASDAQ:ZURA) reported second-quarter results that landed on an unusual mix of good and bad news. The clinical-stage biotech finished enrolling two separate Phase 2 studies of its lead drug, tibulizumab, both ahead of their original targets, while a widening net loss showed just how much it costs to run them. […]

      Sep 11Yahoo FinanceZURA
      Zura Bio at 12th annual cantor fitzgerald global healthcare conference: data ahead
      Sep 9Investing.comZURA
      Zura Bio to Participate in the Cantor Global Healthcare Conference

      HENDERSON, Nev., August 31, 2026--Zura Bio Limited (Nasdaq: ZURA) ("Zura"), a clinical-stage biotechnology company developing novel and differentiated medicines to meaningfully improve the lives of patients with serious and debilitating autoimmune and inflammatory diseases, today announced that members of its management team will participate in the following upcoming investor conference:

      Aug 31Yahoo FinanceZURA
      Zura Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

      HENDERSON, Nev., August 21, 2026--Zura Bio Limited (Nasdaq: ZURA) ("Zura" or the "Company"), a clinical-stage biotechnology company developing novel and differentiated medicines to meaningfully improve the lives of patients with serious and debilitating autoimmune and inflammatory diseases, today reported that on August 20, 2026, the Company granted inducement awards consisting of options to purchase up to 587,000 Class A Ordinary Shares (the "Options") to thirteen newly hired employees. These a

      Aug 21Yahoo FinanceZURA

      This is the newest page. Registered accounts read further back.